Palopegteriparatide
Medication / From Wikipedia, the free encyclopedia
Palopegteriparatide, sold under the brand name Yorvipath, is a hormone replacement therapy used for the treatment of chronic hypoparathyroidism.[1] It is a transiently pegylated parathyroid hormone.[3]
Quick Facts Clinical data, Trade names ...
Clinical data | |
---|---|
Trade names | Yorvipath |
Other names | ACP-014, TransCon PTH |
Routes of administration | Subcutaneous |
Drug class | Hormonal agent |
ATC code | |
Legal status | |
Legal status | |
Identifiers | |
CAS Number | |
UNII | |
KEGG |
Close